Zonegran

Product manufactured by Eisai Inc.

Application Nr Approved Date Route Status External Links
NDA020789 2003-08-22 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Zonegran Is Indicated As Adjunctive Therapy In The Treatment Of Partial Seizures In Adults With Epilepsy.

All Formulated Excipients (3 Total)

Name Structure Kind Function Status
1. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
2. Sodium Lauryl Sulfate SODIUM LAURYL SULFATE Molecular AF-Antifoaming (or defoaming) agent , CTG-Component or coating , EMUL-Emulsifier , SANI-Sanitizing agent , SDA-Solubilizing & dispersing agent REG-Food additives for which a petition has been filed and a regulation issued.
3. Gelatin GELATIN Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Zonisamide ZONISAMIDE ZINC4321

Comments